Roberta Pantani, Director of Regulatory Affairs
Professional Overview
Roberta Pantani is an accomplished regulatory affairs professional with extensive experience in the pharmaceutical and biotechnology industries. As the Director of Regulatory Affairs, she currently oversees the strategic management of regulatory compliance and submission processes for Calcilytix Theraputics Inc., a BridgeBio Company. Roberta's expertise spans a wide range of therapeutic areas, including rare diseases and specialty pharmaceuticals.
Experience Summary
Current Role
Roberta currently serves as the Vice President of Regulatory Affairs at Calcilytix Theraputics Inc., a BridgeBio Company, where she is responsible for leading the company's regulatory strategy and ensuring compliance with global regulations. In this role, she has successfully guided the development and submission of multiple regulatory filings, contributing to the advancement of the company's pipeline.
Career Progression
Prior to her current position, Roberta held senior regulatory affairs roles at various pharmaceutical and biotechnology companies, including Myovant Sciences, Raptor Pharmaceuticals, and Relypsa. Throughout her career, she has demonstrated a strong track record of collaborating with cross-functional teams, navigating complex regulatory landscapes, and driving the successful approval of innovative therapies.
Academic Background
Roberta holds a Bachelor of Science degree in Pharmaceutical Sciences from the University of California, San Francisco, where she graduated with distinction.
Areas of Expertise
Roberta's areas of expertise include:
- Regulatory strategy development and implementation
- Global regulatory submissions and approvals
- Regulatory compliance and risk mitigation
- Stakeholder management and cross-functional collaboration
- Project management and strategic decision-making
Professional Impact
Roberta has made significant contributions to the pharmaceutical and biotechnology industries through her leadership in regulatory affairs. She has successfully guided the development and approval of several innovative therapies, helping to bring life-changing treatments to patients in need. Roberta's industry expertise and strategic vision have positioned her as a trusted advisor and thought leader within the regulatory affairs community.
Conclusion
With her deep regulatory knowledge, proven track record of success, and commitment to driving innovation, Roberta Pantani is poised to continue making a meaningful impact in the pharmaceutical and biotechnology sectors. Her demonstrated ability to navigate complex regulatory landscapes and deliver tangible results make her a valuable asset to any organization seeking to navigate the ever-evolving regulatory landscape.
